| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $25.2M | +886.8% |
| R&D Expense | $36.4M | +67.1% |
| SG&A Expense | $12.8M | +22.8% |
| Operating Income | -$24.1M | +18.9% |
| Net Income | -$22.3M | +23.2% |
| EPS (Basic) | -$0.83 | +29.7% |
| EPS (Diluted) | -$0.83 | +29.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.7M | +53.0% |
| Short-term Investments | $24.8M | -22.1% |
| Current Assets | $50.9M | +18.6% |
| Total Assets | $58.7M | +17.2% |
| Current Liabilities | $31.3M | +32.6% |
| Total Liabilities | $36.1M | -5.7% |
| Stockholders' Equity | $22.6M | +91.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$25.6M | -620.6% |
| Capital Expenditures | $1.3M | -34.4% |
| Investing Cash Flow | $5.1M | +114.6% |
| Financing Cash Flow | $25.6M | +424.8% |
| Free Cash Flow | -$26.9M | -1022.7% |